Mary Wilson
Well-known member
this version posted May 27, 2022
medRxiv preprint doi: https://doi.org/10.1101/2022.05.25.22275533
Ana S. Gonzalez-Reiche, Hala Alshammary, Sarah Schaefer, Gopi Patel, Jose Polanco, Angela A. Amoako, Aria Rooker, Christian Cognigni, Daniel Floda, Adriana van de Guchte, Zain Khalil, Keith Farrugia, Nima Assad, Jian Zhang, Bremy Alburquerque, Levy Sominsky, Komal Srivastava, Robert Sebra, Juan David Ramirez, Radhika Banu, Paras Shrestha, Alberto Paniz-Mondolfi, Emilia Mia Sordillo, Viviana Simon, Harm van Bakel
Abstract
Persistent SARS-CoV-2 infections have been reported in immune-compromised individuals and people undergoing immune-modulatory treatments. It has been speculated that the emergence of antigenically diverse SARS-CoV-2 variants such as the Omicron variant may be the result of intra-host viral evolution driven by suboptimal immune responses, which must be followed by forward transmission. However, while intrahost evolution has been documented, to our knowledge no direct evidence of subsequent forward transmission is available to date. Here we describe the emergence of an Omicron BA.1 sub-lineage with 8 additional amino acid substitutions within the spike (E96D, L167T, R346T, L455W, K458M, A484V, H681R, A688V) in an immune-compromised host along with evidence of 5 forward transmission cases. Our findings show that the Omicron BA.1 lineage can further diverge from its exceptionally mutated genome during prolonged SARS-CoV-2 infection; highlighting an urgent need to employ therapeutic strategies to limit duration of infection and spread in vulnerable patients.
https://www.medrxiv.org/content/10.1101/2022.05.25.22275533v1.full.pdf
medRxiv preprint doi: https://doi.org/10.1101/2022.05.25.22275533
Ana S. Gonzalez-Reiche, Hala Alshammary, Sarah Schaefer, Gopi Patel, Jose Polanco, Angela A. Amoako, Aria Rooker, Christian Cognigni, Daniel Floda, Adriana van de Guchte, Zain Khalil, Keith Farrugia, Nima Assad, Jian Zhang, Bremy Alburquerque, Levy Sominsky, Komal Srivastava, Robert Sebra, Juan David Ramirez, Radhika Banu, Paras Shrestha, Alberto Paniz-Mondolfi, Emilia Mia Sordillo, Viviana Simon, Harm van Bakel
Abstract
Persistent SARS-CoV-2 infections have been reported in immune-compromised individuals and people undergoing immune-modulatory treatments. It has been speculated that the emergence of antigenically diverse SARS-CoV-2 variants such as the Omicron variant may be the result of intra-host viral evolution driven by suboptimal immune responses, which must be followed by forward transmission. However, while intrahost evolution has been documented, to our knowledge no direct evidence of subsequent forward transmission is available to date. Here we describe the emergence of an Omicron BA.1 sub-lineage with 8 additional amino acid substitutions within the spike (E96D, L167T, R346T, L455W, K458M, A484V, H681R, A688V) in an immune-compromised host along with evidence of 5 forward transmission cases. Our findings show that the Omicron BA.1 lineage can further diverge from its exceptionally mutated genome during prolonged SARS-CoV-2 infection; highlighting an urgent need to employ therapeutic strategies to limit duration of infection and spread in vulnerable patients.
https://www.medrxiv.org/content/10.1101/2022.05.25.22275533v1.full.pdf